Clinical Trials
3 trialsNCT07541664 2026-04-21
Digital Mind-Body Therapy for Neoadjuvant Breast Cancer
Fudan University
Phase NA Recruiting
NCT07054242 2025-10-01
A Prospective, Single-center, Phase II Study of Sacituzumab Tirumotecan in Combination With Pembrolizumab for Neoadjuvant Treatment of Triple-Negative Breast Cancer (TNBC)
Yantai Yuhuangding Hospital
Phase 2 Not yet recruiting
NCT06734702 2025-07-24
Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer
Sun Yat-sen University
Phase 3 Recruiting